May 15, 2017 / 12:48 PM / 2 months ago

BRIEF-Onconova Therapeutics Q1 loss per share $1.23

1 Min Read

May 15 (Reuters) - Onconova Therapeutics Inc

* Onconova therapeutics, inc. Reports recent business highlights and first quarter 2017 financial results

* Q1 revenue $200,000 versus $1.5 million

* Onconova therapeutics inc - believes that its current cash and cash equivalents will be sufficient to fund its ongoing trials and operations to end of 2017

* Onconova therapeutics inc - cash and cash equivalents as of march 31, 2017, totaled $15.4 million, compared to $21.4 million as of december 31, 2016

* Q1 loss per share $1.23

* Q1 earnings per share view $-1.01, revenue view $160000.00 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below